+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Bromides 18071-51-7
18071-51-7,MFCD00464941
Catalog No.:AA00226F

18071-51-7 | Methyl 5-bromo-2-hydroxy-3-iodobenzoate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>97%
1 week  
$299.00   $209.00
- +
5mg
>97%
1 week  
$319.00   $223.00
- +
10mg
>97%
1 week  
$358.00   $250.00
- +
500mg
>97%
1 week  
$453.00   $317.00
- +
1g
>97%
1 week  
$589.00   $412.00
- +
5g
>97%
1 week  
$1,337.00   $936.00
- +
10g
>97%
1 week  
$2,347.00   $1,643.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00226F
Chemical Name:
Methyl 5-bromo-2-hydroxy-3-iodobenzoate
CAS Number:
18071-51-7
Molecular Formula:
C8H6BrIO3
Molecular Weight:
356.9399
MDL Number:
MFCD00464941
SMILES:
COC(=O)c1cc(Br)cc(c1O)I
Properties
Computed Properties
 
Complexity:
200  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP3135667,2017,A1Locationinpatent:Paragraph0501

[2]Locationinpatent:experimentalpartEl-Kabbani,Ossama;Scammells,PeterJ.;Gosling,Joshua;Dhagat,Urmi;Endo,Satoshi;Matsunaga,Toshiyuki;Soda,Midori;Hara,Akira[JournalofMedicinalChemistry,2009,vol.52,#10,p.3259-3264]

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP3135667,2017,A1Locationinpatent:Paragraph0499-0500

[2]Cherney,EmilyC.;Zhang,Liping;Lo,Julian;Huynh,Tram;Wei,Donna;Ahuja,Vijay;Quesnelle,Claude;Schieven,GaryL.;Futran,Alan;Locke,GregoryA.;Lin,Zeyu;Monereau,Laura;Chaudhry,Charu;Blum,Jordan;Li,Sha;Fereshteh,Mark;Li-Wang,Bifang;Gangwar,Sanjeev;Pan,Chin;Chong,Colin;Zhu,Xiao;Posy,ShanaL.;Sack,JohnS.;Zhang,Ping;Ruzanov,Max;Harner,Mary;Akhtar,Fahad;Schroeder,GretchenM.;Vite,Gregory;Fink,Brian[JournalofMedicinalChemistry,2022,vol.65,#4,p.3518-3538]

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2022/169921,2022,A1Locationinpatent:Page/Pagecolumn56-57;149-150

[4]CurrentPatentAssignee:KARYOPHARMTHERAPEUTICSINC-WO2015/3166,2015,A1Locationinpatent:Paragraph00705

[5]Locationinpatent:experimentalpartEl-Kabbani,Ossama;Scammells,PeterJ.;Gosling,Joshua;Dhagat,Urmi;Endo,Satoshi;Matsunaga,Toshiyuki;Soda,Midori;Hara,Akira[JournalofMedicinalChemistry,2009,vol.52,#10,p.3259-3264]

18071-51-7   
diethyl2,3-diazabicyclo2.2.1hept-5-ene-2,3-dicarboxylate 
 
C19H21BrN2O7 
 
C19H23BrN2O7 

[1]Prasad,B.A.Bhanu;Buechele,AlexanderE.;Gilbertson,ScottR.[OrganicLetters,2010,vol.12,#23,p.5422-5425]

18071-51-7   
(E)-3-(6-aminopyridin-3-yl)-N-((5-(5-(4,4-difluoropiperidine-1-carbonyl)pyridin-2-yl)-7-(1,3,4-oxadiazol-2-yl)benzofuran-2-yl)methyl)acrylamide 

[1]CurrentPatentAssignee:KARYOPHARMTHERAPEUTICSINC-WO2015/3166,2015,A1

18071-51-7   
methyl2-((tert-butoxycarbonylamino)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzofuran-7-carboxylate 

[1]CurrentPatentAssignee:KARYOPHARMTHERAPEUTICSINC-WO2015/3166,2015,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 18071-51-7
188813-07-2

188813-07-2

 186772-44-1

186772-44-1

 1370600-52-4

1370600-52-4

 1155261-81-6

1155261-81-6

 1092308-85-4

1092308-85-4
Building Blocks
More >
Tags:18071-51-7 Molecular Formula|18071-51-7 MDL|18071-51-7 SMILES|18071-51-7 Methyl 5-bromo-2-hydroxy-3-iodobenzoate